戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              POC Hgb levels correlated with hematology analyzer Hgb l
2                                              POC positioning of the Xpert test led to more rapid init
3                                              POC test outcome concordance with conventional test resu
4                                              POC testing has a variety of advantages including the ab
5                                              POC US is increasingly used by clinicians and is an esse
6                                              POC-CD4 could have the greatest impact on mortality in s
7                                              POC-CD4 improves clinical outcomes and remains near the
8                                              POC/water-partitioning coefficients (KPOC) were orders o
9 OC-CD4, 85%), and test cost (LAB-CD4, US$10; POC-CD4, US$24).
10 T ineligibility (specificity: LAB-CD4, 100%; POC-CD4, 85%), and test cost (LAB-CD4, US$10; POC-CD4, U
11 RT) eligibility (sensitivity: LAB-CD4, 100%; POC-CD4, 90%) or ART ineligibility (specificity: LAB-CD4
12 med at a district hospital laboratory or (2) POC Xpert MTB/RIF test performed at a primary health car
13 eters include linkage to care (LAB-CD4, 34%; POC-CD4, 61%), probability of correctly detecting antire
14 er bioassay applications or development as a POC diagnostic tool.
15                  To evaluate the effect of a POC diagnostic strategy on initiation of appropriate TB
16 rature (~60 degrees C), or at end-point on a POC photon counter only holding environmental temperatur
17 eded; those who were ART-eligible received a POC tuberculosis (TB) test if symptomatic, POC blood tes
18                              Rapid, accurate POC diagnostic assays play a crucial role in developing
19 mented as the core technology in stand-alone POC tests, for use in mobile or rural settings.
20                            Life-cycle BC and POC emissions have small impacts on life-cycle greenhous
21  20 year Global Warming Potentials of BC and POC emissions, respectively, for vehicles fueled with co
22 educed from those without considering BC and POC emissions.
23 rcane-derived ethanol, mostly due to BC- and POC-intensive biomass-fired boilers in cellulosic and su
24 ting a considerable promise for low-cost and POC NAT in remote areas.
25 bed sites invariably released modern DOC and POC (<20 years old), and seasonal forcing had little imp
26                  Sorption of PACs to DOC and POC was important for the mobility of compounds with log
27                             The 3 antibiotic POC test delayed the time to reach 1% prevalence of trip
28  point-of-care circulating cathodic antigen [POC-CCA] urine cassette test) in 107 newly arrived asymp
29 sible for the important transfer of CO2-C as POC "Particulate Organic Carbon" to the deep sea.
30 facilities in developed countries as well as POC diagnostics in resource-poor and developing countrie
31  the importance of temperature, we assembled POC measurements in two global sets of drill sites where
32 improve access and uptake of quality-assured POC tests to ensure coverage and public health impact.
33 gy could enable rapid detection of beta-A at POC and may facilitate fast personalized health care del
34 r, the implementation of these techniques at POC application is limited due to longer analysis time,
35 or ages 5-10 Ma, the decrease of the average POC content with burial is clearly more pronounced in th
36 al sediment yield, we calculate a biospheric POC flux of 2.2(+1.3)(-0.9) teragrams of carbon per year
37 ur samples reveal that the eroded biospheric POC has resided in the basin for millennia, with a mean
38                 From the measured biospheric POC content and variability in annual sediment yield, we
39  erosion rates affect the rate of biospheric POC burial in marine sediments more strongly than carbon
40        We conclude that burial of biospheric POC in marine sediments becomes the dominant long-term a
41                      We find that biospheric POC export is primarily controlled by the capacity of ri
42 l due to the chemical instability of the bis-POC/POM derivatives.
43  and smartphone app, respectively), and both POC test methods yielded comparable sensitivity and spec
44               This study confirmed that both POC technologies can be successfully used outside the la
45 treatment (B and C), and treatment guided by POC tests determining susceptibility to (2) A only and (
46 particulate, humus, and resistant organic C (POC, HOC, and ROC, respectively), clay content, cation e
47                       Pentalogy of Cantrell (POC) is an extremely rare and complex congenital anomaly
48                       Pentalogy of Cantrell (POC) is an extremely rare and complex syndrome of numero
49    The export of particulate organic carbon (POC) from the surface ocean to depth is traditionally as
50 which transports particulate organic carbon (POC) from the surface to the deep ocean, plays an import
51 PACs) to DOC and particulate organic carbon (POC) in 10 historically contaminated soils.
52 flux and fate of particulate organic carbon (POC) in large rivers at high latitudes remains poorly co
53        Fluxes of particulate organic carbon (POC) in the East China Sea (ECS) have been reported to d
54 n of sedimentary particulate organic carbon (POC) is a key carbon cycle process that fuels the deep s
55 se a fraction as particulate organic carbon (POC) that sinks into the ocean interior.
56 verine export of particulate organic carbon (POC) to the ocean affects the atmospheric carbon invento
57 lack carbon (BC) and primary organic carbon (POC).
58  restrictions when applied to point of care (POC) applications.
59 l clinical setting and in the point of care (POC) arena.
60 udes with a discussion on the point-of care (POC) assay for a fast, accurate and ability of handling
61 ltiplexed rapid lab-on-a-chip point of care (POC) assay for the serologic diagnosis of human Lyme dis
62  of Ebola virus (EBOV) at the point of care (POC) directly from blood samples is described.
63 rate diagnosis of disease for point of care (POC) technologies.
64 ich hold immense potential as point of care (POC) tools.
65 l suitable for further use as point-of-care (POC) analysis and ii) two dedicated image processing alg
66 on of economical, disposable, point-of-care (POC) analytical devices.
67  molecular diagnostics at the point-of-care (POC) and in resource-limited settings is the lack of sen
68 hrome c (cyt c) detection, at point-of-care (POC) application.
69 feasibility of the sensor for point-of-care (POC) applications was further demonstrated by determinin
70 nable to clinical and in-home point-of-care (POC) applications.
71 tudy ("rapid arm") received a point-of-care (POC) CD4 count if needed; those who were ART-eligible re
72  In this study, a paper-based point-of-care (POC) colorimetric biosensor was developed for the detect
73 uting power could be an ideal point-of-care (POC) colorimetric detection device for the next-generati
74 ed to develop next generation point-of-care (POC) detection system.
75 legant solution for low-cost, point-of-care (POC) devices and lab-on-a-chip (LOC) applications.
76                  Quantitative point-of-care (POC) devices are the next generation for serological dis
77 mising opportunity to develop Point-of-Care (POC) devices for an efficient, simple and accurate glute
78 nciple for the development of point-of-care (POC) devices for in situ screening of V. cholerae relate
79                  Microfluidic point-of-care (POC) devices have been designed to address these needs,
80 roach has great potential for point-of-care (POC) diagnosis of multiple infectious diseases simultane
81 -cost, disposable lab-on-chip point-of-care (POC) diagnosis system.
82 es them an ideal platform for point-of-care (POC) diagnosis, especially in resource-limited settings.
83 s for biomedical research and point-of-care (POC) diagnosis.
84                               Point-of-care (POC) diagnostic biosensors offer a promising solution to
85                               Point-of-care (POC) diagnostic devices are integral in the health care
86 rement for the development of point-of-care (POC) diagnostic technologies for human immunodeficiency
87                               Point-of-care (POC) diagnostic testing platforms are a growing sector o
88 pensive, making them valuable point-of-care (POC) diagnostic tools.
89                               Point-of-care (POC) diagnostics are one of the quick and sensitive dete
90     For the developing world, point-of-care (POC) diagnostics design must account for limited funds,
91 are one of the most prevalent point-of-care (POC) diagnostics due to their simplicity, low cost, and
92 f research in universities on point-of-care (POC) diagnostics for global health, most devices never l
93 As) are highly attractive for point-of-care (POC) diagnostics for infectious disease, food safety, an
94                    RATIONALE: Point-of-care (POC) diagnostics have the potential to reduce pretreatme
95 f nucleic acid biomarkers for point-of-care (POC) diagnostics is currently limited by technical compl
96                               Point-of-care (POC) diagnostics play an important role in delivering he
97                               Point-of-care (POC) diagnostics provide rapid actionable information fo
98 velopments in cloud-connected point-of-care (POC) diagnostics technologies are pushing the frontiers
99 lab-on-chip (LOC) devices for point-of-care (POC) diagnostics, in the medical industry and environmen
100 t and are not appropriate for point-of-care (POC) diagnostics.
101 lthcare is the development of point-of-care (POC) diagnostics.
102 niaturized for application in point-of-care (POC) diagnostics.
103 le, easy-to-use, inexpensive, point-of-care (POC) disposable cassette that carries out all the unit o
104  they are not yet extended at point-of-care (POC) due to sophisticated equipments, need of high exper
105               The established point-of-care (POC) FO-SPR bioassay was also used to measure IFX in 100
106  is one of the most promising point-of-care (POC) gene amplifiers, but has been hard to detect precis
107                   An accurate point-of-care (POC) HIV-1 VL test could alleviate many of these challen
108 ow-cost, high throughput, and point-of-care (POC) infectious disease diagnosis.
109 ctive sensor to detect EVD at point-of-care (POC) is certainly worth exploring to establish rapid dia
110 d easiest way possible at the point-of-care (POC) is still in demand.
111 antify salivary cortisol at a point-of-care (POC) level.
112 vened a colloquium to examine point-of-care (POC) microbiology testing and to evaluate its effects on
113 s, which are not adaptable to point-of-care (POC) needs at resource-constrained as well as primary ca
114           Compared with other point-of-care (POC) nucleic acid tests (NAT), MTNT could assay both DNA
115 g it suitable for a practical point-of-care (POC) platform for low target count clinical applications
116           We have developed a point-of-care (POC) quantitative immunoassay for HbS to serve as a diag
117 ave been extensively used for point-of-care (POC) self-diagnostics, but they have some limitations in
118 y format used in low-resource point-of-care (POC) settings, have limitations that have held back thei
119 olecule drugs and analytes in point-of-care (POC) settings.
120 d treatment monitoring at the point-of-care (POC) settings.
121 dder cancer in clinics and at point-of-care (POC) settings.
122  particularly well suited for point-of-care (POC) specific protein detection, being of low cost, ligh
123                               Point-of-care (POC) technologies for HIV diagnosis in infants have the
124          The development of a point-of-care (POC) test for the disease-associated miRNAs would be esp
125  the impact of a hypothetical point-of-care (POC) test reporting antibiotic susceptibility profiles o
126 y has various applications in point-of-care (POC) testing and diagnostics, ranging from e.g., quantif
127 r microdevice is suitable for point-of-care (POC) testing with high simplicity, providing affordabili
128                 Most syphilis point-of-care (POC) tests detect treponemal antibodies, which persist a
129 adout of biological assays in point-of-care (POC) tests, is presented.
130 t of an inexpensive and rapid point-of-care (POC) tool for bone metabolism detection and prognostics.
131                               Point-of-care (POC) ultrasound has been used by a variety of nonradiolo
132  are too complex or bulky for point-of-care (POC) use.
133                               Point-of-care (POC) viral load measurement is of paramount importance w
134                     Access to point-of-care (POC), rapid, inexpensive, sensitive, and instrument-free
135 entation of biosensors at the point-of-care (POC), such as at primary clinics or the bedside, faces i
136 e-constrained settings at the point-of-care (POC), where reliable electricity and refrigeration are l
137 ing that is deployable at the point-of-care (POC).
138 eld devices to be used at the point-of-care (POC).
139  instruments and 11.0% of CD4 point of care [POC]) and 10% of VL/EID instruments were reportedly not
140 ome laboratory support (e.g., point-of-care [POC] testing) within the room of the isolated patient.
141 rmation of the primary ossification centers (POCs) and secondary ossification centers (SOCs) of mamma
142 ber mixing models to evaluate trap-collected POC fluxes.
143 ics in reducing postoperative complications (POCs) has been questioned.
144 ns in the PK properties of proof-of-concept (POC) compounds to accelerate the development of such rel
145 so confirmed in a clinical proof-of-concept (POC) study.
146 trained, however, and mechanisms controlling POC export have remained elusive, limiting our ability t
147 s for obtaining sensitive, fast and low-cost POC diagnostics.
148 atment was 7 days (laboratory) versus 1 day (POC).
149                          We also demonstrate POC tissue engineering by writing a continuous pattern o
150 d element ratios to correct for rock-derived POC.
151 es provide alternative approaches to develop POC diagnostic assays for broad applications in medicine
152 itive readout holds the potential to develop POC tests, which are able to detect low concentrations o
153 the less sensitive lateral flow and dipstick POC tests are implemented.
154 ce for the next-generation of cost-effective POC diagnostics, immunoassays and diversified bioanalyti
155                         This cost-effective, POC HbS quantitative approach will allow for real-time t
156                                Use of either POC test in 10% of identified cases delayed this by 5 ye
157 at depths of 100 to 350 meters with elevated POC, chlorophyll, oxygen, and temperature-salinity chara
158                                     Emerging POC microbiology tests, especially nucleic acid amplific
159 g devices, designing studies, and evaluating POC diagnostics.
160 technologies as the material for fabricating POC diagnostic systems.
161             Current methods do not allow for POC applications due to several limitations, including s
162 monitoring, and ability to be customized for POC diagnostics.
163                           A major driver for POC development is the ability to diagnose infectious di
164              Although DBS might be ideal for POC, this is the first report of using an SPR biosensor
165 ld-out of instrumentation and tests kits for POC deployment.
166 oscope, which opens up new opportunities for POC diagnostics and sensing applications in resource-lim
167  for integration into portable platforms for POC and in resource-limited settings applications.
168 nts for speed, low cost, and ease of use for POC applications.
169                                       Future POC studies are urgently needed and would benefit from t
170 d selective biosensors for future generation POC tools.
171 shows enormous potential for next-generation POC diagnostics.
172 s present technologies in on-site or at home POC diagnostic assays implemented in paper-based microfl
173 e review recent developments and advances in POC technologies and describe how these advances enhance
174 d always be the primary mode of diagnosis in POC because although Magnetic resonance imaging (MRI) ca
175 nting novices, intermediates, and experts in POC US, scanned 4 different surgical patient cases in a
176 Ts), magnetic nanoparticles, and graphene in POC devices will be reviewed.
177  pulses during winter can be as important in POC transfer to depth as the pulses associated with spri
178 s on application of emerging technologies in POC diagnostics.
179 -cell "renewable" capture reagent for use in POC diagnostic applications is described.
180  almost all of these clinical lab tests into POC tests that use a PGM.
181                               By introducing POC groups on both the phosphonate and alpha-carboxylate
182               Isopropyloxycarbonyloxymethyl (POC) ester 30 was the only prodrug that achieved substan
183 hyl (POM) and isopropyloxycarbonyloxymethyl (POC) while keeping the alpha- and gamma-carboxylates uns
184                       The factors that limit POC testing to become real world products and future dir
185 east equal or better than current mainstream POC devices.
186 es a facile platform for easily manufactured POC sensors.
187 mited research supports the notion that many POC ultrasound applications practiced by nonradiologist
188                                   While many POC tests are based on chromatographic flow assay techno
189 eviously unpublished profiles of mesopelagic POC flux derived from neutrally buoyant sediment traps d
190 o, 6 h) and blood glucose reduction in mice (POC = -45%; 100 mg/kg po, 3 h).
191 s the differential diagnoses which can mimic POC.
192  random permuted blocks, to have a molecular POC test for respiratory viruses or routine clinical car
193                           We evaluated a new POC test, incorporating a nontreponemal component, to di
194 ned challenges facing the development of new POC diagnostics.
195                    Furthermore, there are no POC assays available for CCHF.
196 water with high concentrations of nonsinking POC.
197 he Eastern Tropical North Pacific OMZ 70% of POC remineralization is due to microbial respiration, in
198 alidity of the OSAUS scale for assessment of POC US competence.
199 nd and other imaging modalities in a case of POC as well as the differential diagnoses which can mimi
200 irst time in literature, a recurrent case of POC detected in the first trimester in a mother whose pr
201 ool and is indispensible in the diagnosis of POC.
202 y reproducible imaging tool for diagnosis of POC.
203 medically due to the ultrasound diagnosis of POC.
204 tracers to provide quantitative estimates of POC fluxes in marginal seas.
205 implementation, oversight, and evaluation of POC microbiology testing.
206 ch as half of the total springtime export of POC from the highly productive subpolar oceans.
207      Such a submesoscale eddy-driven flux of POC is unresolved in global carbon cycle models but can
208 cs technologies are pushing the frontiers of POC devices toward low-cost, user-friendly, and enhanced
209                          One of the goals of POC testing is the development of a chip-based, miniatur
210 800 (95% CI, US$2,790-US$2,800); the ICER of POC-CD4 compared to LAB-CD4 is US$500/year of life saved
211  during the spring transition, intrusions of POC-rich surface water descend as coherent, 1- to 10-kil
212 c communities is the integrated magnitude of POC reaching the seafloor rather than its seasonal patte
213                   Currently, the majority of POC diagnostics utilize paper substrates owing to afford
214 course of the pregnancy or the management of POC.
215  seasonal responses to differing patterns of POC forcing, with both a decline in seasonal variability
216 fabrication and improving the performance of POC devices.
217 ow these advances enhance the performance of POC platforms.
218                        Despite the rarity of POC, it is imperative for a radiologist to be aware of i
219 e of the fundamental controls on the rate of POC degradation within deeply buried marine sediments.
220 h should have resulted in different rates of POC degradation.
221                            The reactivity of POC is expected to decrease with increasing sediment age
222 likely lead to shallower remineralization of POC and hence reduced storage of CO2 by the ocean.
223 uring thus all the essential requirements of POC tests.
224                                 Scenarios of POC forcing under climate change and ocean acidification
225 scales, the balance between sequestration of POC from the terrestrial biosphere and oxidation of rock
226              Here, we quantify the source of POC in the Mackenzie River, the main sediment supplier t
227 rank the effectiveness of these therapies on POCs in adult surgical patients.
228 ng unnecessary treatment compared with other POC tests.
229           We demonstrated the utility of our POC diagnostic system by detecting ZIKV in oral samples
230  initial phospholane, reaction products (PCO/POC-isomers), and an intermediate P(V)-oxaphosphirane.
231                   Mild hydrolysis of the PCO/POC-isomers proceeds with a high chemoselectivity and le
232 h care professionals in the use of pediatric POC ultrasound, as well as the necessity of diverse rese
233 ed to the continued development of pediatric POC ultrasound, there is potential for useful applicatio
234 ort yields of both biospheric and petrogenic POC are positively related to the yield of suspended sed
235   Here we estimate biospheric and petrogenic POC fluxes for a suite of river systems representative o
236 stimates of global biospheric and petrogenic POC fluxes of 157(+74)(-50) and 43(+61)(-25) megatonnes
237 fying key experimental designs for potential POC assays.
238 17 item total score, although the predefined POC efficacy criterion (probability of LY2940094 being b
239 ned elusive, limiting our ability to predict POC fluxes quantitatively as a result of climatic or tec
240 nbiotics as an adjunctive therapy to prevent POCs among adult surgical patients.
241  biomarkers, and could be adapted to provide POC diagnostics for a range of pathogens.
242                                    Recently, POC ultrasound use by pediatricians has received increas
243 ever, the molecular mechanisms that regulate POC and SOC formation are different.
244 in the magnitude and seasonality of seafloor POC fluxes, as well as the importance of studying a broa
245 benthic biomass model, BORIS, using seafloor POC flux from a coupled ocean-biogeochemistry model, NEM
246 ll to develop rapid, selective and sensitive POC detection of EBOV for global health care.
247                 We envisage that this simple POC hybrid microplate can have broad applications in var
248   Results suggest that sorption to (sinking) POC was the dominant removal process for hydrophobic pol
249 anges into the thermodynamically more stable POC-isomer of the cage-like phosphorane.
250 uring burial have been proposed to stimulate POC degradation, possibly supplying significant energy t
251                  The proof-of-concept study (POC) was an 8-week, double-blind, placebo-controlled tri
252                                   Subsequent POC tests are positive, despite no active infection, and
253 a POC tuberculosis (TB) test if symptomatic, POC blood tests, physical exam, education, counseling, a
254  yield of suspended sediment, revealing that POC export is mostly controlled by physical erosion.
255               Recent research has shown that POC fluxes in the ECS may be overestimated due to active
256                                          The POC Cepheid Xpert HIV-1 VL assay is a promising tool for
257                                          The POC Cepheid Xpert HIV-1 VL assay showed high agreement a
258                                          The POC device and assay developed offer portability, smalle
259                                          The POC system can be expanded to detect a number of miRNAs
260                                          The POC technologies yielded 102 positive and 220 negative t
261                                          The POC Xpert HIV-1 VL assay tended to overestimate HIV-1 VL
262 n and/or quantification of biomarkers at the POC and primary care settings.
263 to capture and detect other pathogens at the POC and primary care settings.
264 ed whole blood targeting applications at the POC such as HIV management and monitoring.
265 endly, and compact biosensing systems at the POC.
266 omarker detection for cancer patients at the POC.
267 vice for rapid diagnosis of active TB at the POC.
268 PC-based biosensors and their promise at the POC.
269 te methods for detection of pathogens at the POC.
270                                     Both the POC Xpert HIV-1 VL and Abbott assays were performed on s
271                                 Finally, the POC FO-SPR immunoassay was validated by using matching s
272              This review also highlights the POC cyt c biosensors developed recently, that would prov
273 76.5% in the laboratory arm and 79.5% in the POC arm (odds ratio, 1.13; 95% confidence interval, 0.51
274 olled (646 in the laboratory arm, 651 in the POC arm), 159 (12.4%) of whom had culture-positive PTB.
275                     Acidic hydrolysis of the POC-isomer leads to the formation of an oxirane derivati
276  of 5,800 +/- 800 years, much older than the POC in large tropical rivers.
277 ity of the ethyl ester of benzoate while the POC group was rapidly hydrolyzed.
278 eveloped system is ready to be applicable to POC diagnostics.
279 for the translation of these developments to POC settings, including the performance attributes and m
280 enable to multiplexing, easily integrated to POC devices, and has the potential to impact a wide rang
281 : air-water exchange, reversible sorption to POC, changes in mixed layer depth, removal by sinking pa
282 e advantage over the standard method towards POC applications.
283 chemical beta-A sensing technologies towards POC application to AD management.
284 ed settings, cost and storage of traditional POC immunoassays often limit actual deployment.
285 capacity of rivers to mobilize and transport POC, and is largely insensitive to the magnitude of terr
286 e and alpha-carboxylate, we synthesized Tris-POC-2-PMPA (21b), which afforded excellent release of 1
287 t our FO-SPR biosensor can be used as a true POC diagnostic tool for determining IFX concentrations i
288 th ACEK capacitive sensing to produce a true POC technology.
289 udy aimed to evaluate the performance of two POC technologies against the current standard-of-care (S
290                                      The two POC technologies demonstrated excellent concordance, wit
291  of a concordant positive serology and urine POC-CCA test, which we consider to be a suitable surroga
292        The combination of serology and urine POC-CCA testing detected all 23 microscopy-positive stud
293 00%), the combination of serology plus urine POC-CCA testing appears to be the most sensitive screeni
294 nsitivity) and 21 were positive by the urine POC-CCA test (91.3% sensitivity).
295 rotocol is an important step toward a useful POC device and assay.
296 erved variability in attenuation of vertical POC flux can largely be explained by temperature, with s
297 creasing to 65.0% (95% CI, 64.9%-65.1%) with POC-CD4.
298 95% CI, US$2,440-US$2,450) and increase with POC-CD4 to 10.3 y (95% CI, 10.3-10.3 y) and US$2,800 (95
299 compared hematology analyzer Hgb levels with POC Hgb levels, which were estimated via visual interpre
300          Continued empiric treatment without POC testing was projected to result in >5% of isolates b

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top